These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Successful treatment of hidradenitis suppurativa and Crohn's disease with combined guselkumab and apremilast. Agud-Dios M; Arroyo-Andrés J; Rubio-Muñiz C; Postigo-Lorente C Dermatol Ther; 2022 Oct; 35(10):e15743. PubMed ID: 35904888 [No Abstract] [Full Text] [Related]
30. Development of hidradenitis suppurativa in a patient treated with ustekinumab for her psoriasis: A potential paradoxical reaction? Gkini MA; Bewley AP Dermatol Ther; 2018 Nov; 31(6):e12742. PubMed ID: 30221819 [No Abstract] [Full Text] [Related]
31. Case of bullous pemphigoid under treatment with adalimumab for hidradenitis suppurativa. Sugaya M; Ishii M; Takahashi-Shishido N; Ichimura Y; Morimura S J Dermatol; 2021 Apr; 48(4):e163-e164. PubMed ID: 33502014 [No Abstract] [Full Text] [Related]
32. Twenty-four-week interim analysis from a phase 3 open-label trial of adalimumab in Japanese patients with moderate to severe hidradenitis suppurativa. Morita A; Takahashi H; Ozawa K; Imafuku S; Nakama T; Takahashi K; Matsuyama T; Okubo Y; Kitamura S; Matsuda N; Zhao Y; Yokoyama M; Hayashi N; Terui T J Dermatol; 2019 Sep; 46(9):745-751. PubMed ID: 31282051 [TBL] [Abstract][Full Text] [Related]
34. Is it worthy to treat hidradenitis suppurativa with adalimumab in patients with melanoma and other debilitating systemic diseases? A series of clinical dilemmas. Zhao CY; Fernández-Peñas P Australas J Dermatol; 2018 Nov; 59(4):e297-e298. PubMed ID: 29672833 [No Abstract] [Full Text] [Related]
35. Inverse psoriasis on pre-existing hidradenitis suppurativa lesions: Reply to "A case series of tumor necrosis factor inhibitor-induced psoriasis in patients with hidradenitis suppurativa". Baskurt D; Dogan PE; Mericoz CA; Demirkesen C; Vural S Dermatol Online J; 2024 Jun; 30(3):. PubMed ID: 39090054 [No Abstract] [Full Text] [Related]
36. Successful use of guselkumab in the treatment of severe hidradenitis suppurativa. Kearney N; Byrne N; Kirby B; Hughes R Clin Exp Dermatol; 2020 Jul; 45(5):618-619. PubMed ID: 32068912 [No Abstract] [Full Text] [Related]
38. Pharmaceutical Benefits Scheme listing of adalimumab for hidradenitis suppurativa: Is hidradenitis suppurativa a life-changing drug or does lifestyle change the drug? Vekic DA; Frew JW Australas J Dermatol; 2018 Aug; 59(3):e243-e244. PubMed ID: 29285755 [No Abstract] [Full Text] [Related]
40. NICE approval of adalimumab for moderate-to-severe hidradenitis suppurativa: the end of the beginning for hidradenitis suppurativa therapeutics? Ingram JR; Burton T Br J Dermatol; 2017 Feb; 176(2):281-282. PubMed ID: 28244073 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]